Future Oncology, Volume 19, Issue 34 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Future Oncology, Volume 19, Issue 34 (2023)

See all volumes and issues
Vol 20, 2024 Volume 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Addressing Environmental Pollution and Cancer: the Imperative of the 2030 Agenda
Rita Bonfiglio, Manuel Scimeca & Alessandro Mauriello
Pages: 2273-2276
Published online: 03 Nov 2023
First Page PreviewforAddressing Environmental Pollution and Cancer: the Imperative of the 2030 Agenda | Full Text | References | PDF (1.3 MB) | EPUB
  • 32 Views
  • 0 CrossRef citations
  • 0Altmetric

Plain Language Summary of Publication

Plain Language Summary of Publication
Plain Language Summary of the TOPAZ-1 Study: Durvalumab and Chemotherapy for Advanced Biliary Tract Cancer
Do-Youn Oh, Aiwu Ruth He, Shukui Qin, Li-Tzong Chen, Takuji Okusaka, Arndt Vogel, Jin Won Kim, Thatthan Suksombooncharoen, Myung Ah Lee, Masayuki Kitano, Howard Burris, Mohamed Bouattour, Suebpong Tanasanvimon, Mairead G. McNamara, Renata Zaucha, Antonio Avallone, Benjamin Tan, Juan Cundom, Choong-kun Lee, Hidenori Takahashi, Masafumi Ikeda, Jen-Shi Chen, Julie Wang, Mallory Makowsky, Nana Rokutanda, Magdalena Żotkiewicz, John F. Kurland, Gordon Cohen & Juan W. Valle
Pages: 2277-2289
Published online: 25 Sep 2023
AbstractforPlain Language Summary of the TOPAZ-1 Study: Durvalumab and Chemotherapy for Advanced Biliary Tract Cancer | PDF (1.7 MB)
  • 3522 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Clinical Trial Protocol

Review Article
Phase II multicenter trial: first-line immunochemotherapy with or without radiotherapy in metastatic esophageal squamous cell cancer (SCR-ESCC-01)
Yue Li, Lin Lin, Jun Liu, Xu-Wei Cai, Qin Zhang, Xin-Yun Song, Sheng-Guang Zhao, Xiu-Mei Ma, Xiao-long Fu & Wen Yu
Pages: 2291-2296
Published online: 08 Nov 2023
AbstractforPhase II multicenter trial: first-line immunochemotherapy with or without radiotherapy in metastatic esophageal squamous cell cancer (SCR-ESCC-01) | Full Text | References | PDF (1.3 MB) | EPUB
  • 98 Views
  • 0 CrossRef citations
  • 0Altmetric

Drug Evaluation

Review Article
Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma
Thomas G Martin, Deepu Madduri, Lida Pacaud & Saad Z Usmani
Pages: 2297-2311
Published online: 27 Jul 2023
AbstractforCilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma | Full Text | References | PDF (1.9 MB) | EPUB
  • 3075 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Glycoproteomics-Based Liquid Biopsy: Translational Outlook for Colorectal Cancer Clinical Management in Southeast Asia
Gaayathri Kumarasamy, Nurul Hakimah Mohd Salim, Nur Syafiqah Mohd Afandi, Mohd Afiq Hazlami Habib, Nor Datiakma Mat Amin, Mohd Nazri Ismail & Marahaini Musa
Pages: 2313-2332
Published online: 08 Nov 2023
AbstractforGlycoproteomics-Based Liquid Biopsy: Translational Outlook for Colorectal Cancer Clinical Management in Southeast Asia | Full Text | References | PDF (2.3 MB) | EPUB
  • 88 Views
  • 0 CrossRef citations
  • 0Altmetric

Erratum

Correction
Erratum
Page: 2333
Published online: 20 Oct 2023
CitationforErratum | Full Text | PDF (1.2 MB) | EPUB
  • 170 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Real-world experience of second-line axitinib in metastatic renal cell carcinoma: analysis of the Swedish population
Maria Jakobsson et al.
Rapid Communication | Published online: 26 Jul 2024
Open Access
Prevalence and predictors for cisplatin-induced toxicities in Zimbabwean women with cervical cancer
Oppah Kuguyo et al.
Article | Published online: 26 Jul 2024
Open Access
The TALAPRO-3 study design: a plain language summary
Neeraj Agarwal et al.
Plain Language Summary of Publication | Published online: 24 Jul 2024
Open Access
STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed et al.
Method | Published online: 23 Jul 2024
View all latest articles